Ocugen Inc. stock falls Tuesday, underperforms market | news.google.com • |
Ocugen Inc. stock falls Tuesday, underperforms market | news.google.com • |
Ocugen Inc. stock falls Tuesday, underperforms market | news.google.com • |
Ocugen Extends Cash Runway As OCU400 Nears Key Milestones In Phase 3 | seekingalpha.com • |
Ocugen Extends Cash Runway As OCU400 Nears Key Milestones In Phase 3 | news.google.com • |
NASDAQ: OCGN Investor Notice: Update in Lawsuit for Investors Who Lost Money With Ocugen, Inc. Shares Announced by the Shareholders Foundation | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-08 | 2024-06 | -0.06 | -0.04 | 0.02 | 33.33% |
2024-05-14 | 2024-03 | -0.06 | -0.05 | 0.01 | 16.67% |
2024-04-16 | 2023-12 | 0 | -0.04 | N/A | N/A |
2023-11-09 | 2023-09 | -0.08 | -0.06 | 0.02 | 25.00% |
2023-08-21 | 2023-06 | -0.08 | -0.1 | -0.02 | -25.00% |
2023-05-05 | 2023-03 | -0.11 | -0.07 | 0.04 | 36.36% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-30 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-08-22 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-07 | Chardan Capital | Upgrade | Buy | |
2023-04-16 | HC Wainwright & Co. | Upgrade | Buy | |
2023-04-13 | Chardan Capital | Upgrade | Buy | |
2023-02-28 | Chardan Capital | Upgrade | Neutral | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-08-10 | CASTILLO KIRSTEN M | Director | 50.00K | Sale |
2023-01-02 | CRESPO JESSICA | Officer | 163.39K | Stock Award(Grant) |
2021-05-24 | FERNANDES PRABHAVATHI | Director | 0.00 | Sale |
2021-11-01 | KOMPELLA UDAY B. | Director | 0.00 | Sale |
2022-10-05 | KUMAR RAMESH | Director | 0.00 | Sale |
2023-02-15 | MUSUNURI SHANKAR PH.D | Chief Executive Officer | 3.34M | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 11.81M | 6.41M | 4.60% |
2023-06-29 | Luminus Management, LLC | 4.08M | 2.22M | 1.59% |
2023-06-29 | GMT Capital Corp | 3.92M | 2.13M | 1.53% |
2023-06-29 | Blackrock Inc. | 3.91M | 2.12M | 1.52% |
2023-06-29 | JP Morgan Chase & Company | 3.04M | 1.65M | 1.19% |
2023-06-29 | Millennium Management Llc | 3.02M | 1.64M | 1.18% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 7.60M | 4.13M | 2.96% |
2023-06-29 | Vanguard Extended Market Index Fund | 3.06M | 1.66M | 1.19% |
2023-05-30 | Fidelity Extended Market Index Fund | 1.07M | 490.29K | 0.42% |
2023-05-30 | Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 921.56K | 423.92K | 0.36% |
2023-05-30 | Vanguard Health Care Index Fund | 738.21K | 339.58K | 0.29% |
2023-05-30 | Vanguard Russell 2000 Index Fund | 597.25K | 274.74K | 0.23% |
Split | Date |
---|---|
1 : 60 | 2019-09-30 |
-
-
$OCGN, come on Canada, do something right for once and ahead of USA!
-
$OCGN, its a no brainer that OCGN is the best option right now with full defence of the UK variant, and wondering why they couldnt apply for EMergency use and FDA approved Virus use?
I dont want to wait years for this vacine! -
Short .54, potential squeeze incoming
-
USA strongly need for a new therapeutic Cov management, facts.
-
Maybe we can hope in a fast track if Indian variant squeeze in US
-
BLA was expected because of time of emergency has gone
-
Wow so Shanker just executed his right to sell some shares yesterday right before this news, what a great CEO! Definitely not scummy
-
Hey LORD SHANKARA, why you played with little retail player’s money. You shouldn’t have lied to us that EUA is coming in June. YOU DOOMED US. Bag holder for FOREVER $OCGN.
-
-
When I wake up at 4:40am, I thought I am dream dreaming when I look at the ticker and it showed 5 instead of 10. But quickly I realized, Shankar ditched all of us. Yesterday I was believing to the moon, now I am feeling under the earth. $OCGN.
-
-
It’s kind of strange whom they want to vaccinate when almost all of the USA population is vaccinated by end of this year. Shankar is bringing the COVAXIN only for his team and himself in next year. SPEED UP THE PROCESS BRO. $OCGN
-
Any guesses till what point we have to be a bag holder here. Please don’t say Forever. $OCGN. Shankar you ditched us by providing misleading info.
-
Such moves are not unusual for it. $10 by EOD. $OCGN
-
Back in September of 2018 it went from $175 to 30 in one week.then from that a $30 it went to the $0.33.. I said be careful, if you are in the green, just take your profits and don’t wait till it goes back to the $0.30.
-
Open the 5 years chart and you will see how this so call stock had paid their investors.
Look, when this thing drops, it knows how to. What a nightmare!! -
I don’t know why people are worried about CEO selling 2% of his stocks. He is still holding 98%. If he had bad intentions, he would have done other way round.
-
Looks like this is going back to the $1.5 or lower. For the mean time.
-
I’m steel holding.
I think OCGN need to release more information about what fda said.Without this it will be in uncertainty situation
Which lead us all to recalculate our pathRight now I’m thinking positive but as I said OCGN must realest more information
Good luck to all here. It’s to easy moment
️
-
Ocugen Inc. stock falls Tuesday, underperforms market
news.google.com • -
Ocugen Inc. stock falls Tuesday, underperforms market
news.google.com • -
Ocugen Inc. stock falls Tuesday, underperforms market
news.google.com • -
Ocugen Extends Cash Runway As OCU400 Nears Key Milestones In Phase 3
seekingalpha.com • -
Ocugen Extends Cash Runway As OCU400 Nears Key Milestones In Phase 3
news.google.com • -
Ocugen Inc. stock rises Friday, outperforms market
news.google.com • -
Ocugen Provides Business Update with Second Quarter 2024 Financial Results
globenewswire.com • -
Ocugen, Inc. Announces Closing of $35 Million Public Offering of Common Stock
globenewswire.com • -
Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock
globenewswire.com • -
Ocugen, Inc. Announces Proposed Public Offering of Common Stock
globenewswire.com • -
3 Penny Stocks That Could Turn $10K Into $100K in 3 Years
investorplace.com • -
Ocugen: Paradigm Shift Gene Therapy Facing Cash Flow Hurdles
seekingalpha.com •